159 related articles for article (PubMed ID: 6764243)
1. [Congenital pachyonychia treated by oral retinoid].
Rondón Lugo AJ
Med Cutan Ibero Lat Am; 1982; 10(6):395-8. PubMed ID: 6764243
[TBL] [Abstract][Full Text] [Related]
2. [Pachyonychia congenita. Three familial cases. Effects of the treatment by aromatic retinoid (RO 10.9359) (author's transl)].
Dupré A; Christol B; Bonafé JL; Touron P
Ann Dermatol Venereol; 1981; 108(2):145-9. PubMed ID: 7247217
[TBL] [Abstract][Full Text] [Related]
3. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
Mahrle G; Meyer-Hamme S; Ippen H
Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
[TBL] [Abstract][Full Text] [Related]
4. [Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis].
Rüst O; Tufli T
Schweiz Med Wochenschr; 1979 Dec; 109(48):1921-5. PubMed ID: 161414
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
Greig DE; Wishart J; Hodge JL
N Z Med J; 1981 Aug; 94(689):99-100. PubMed ID: 6944653
[TBL] [Abstract][Full Text] [Related]
6. [Oral treatment of lamellar ichthyosis (non-bullous congenital ichthyosiform erythroderma) with an aromatic retinoid (author's transl)].
Frenk E
Dermatologica; 1981; 162(2):91-103. PubMed ID: 7018943
[TBL] [Abstract][Full Text] [Related]
7. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
[TBL] [Abstract][Full Text] [Related]
8. Severe disorders of keratinization: effects of treatment with Tigason (etretinate).
Marks R; Finlay AY; Holt PJ
Br J Dermatol; 1981 Jun; 104(6):667-73. PubMed ID: 7248177
[TBL] [Abstract][Full Text] [Related]
9. A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.
Polano MK; van der Rhee HJ; van der Schroeff JG
Acta Derm Venereol; 1982; 62(4):361-4. PubMed ID: 6183880
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
Pehamberger H; Esca SA; Holubar K
Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336
[TBL] [Abstract][Full Text] [Related]
11. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
Thivolet J; Robart S; Vignon E
Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
[TBL] [Abstract][Full Text] [Related]
12. Tigason (etretinate) treatment in psoriatic arthritis.
Ciompi ML; Bazzichi L; Marotta G; Pasero G
Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251
[TBL] [Abstract][Full Text] [Related]
13. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
Jagell S; Lidén S
Acta Derm Venereol; 1983; 63(1):89-91. PubMed ID: 6191505
[TBL] [Abstract][Full Text] [Related]
14. [Systemic treatment of oral lichen planus with an aromatic retinoid (Ro 10-9359)].
Maidhof R
Z Hautkr; 1979 Oct; 54(19):873-16. PubMed ID: 392969
[TBL] [Abstract][Full Text] [Related]
15. Long-term oral treatment of two pronounced ichthyotic conditions: lamellar ichthyosis and epidermolytic hyperkeratosis with the aromatic retinoid, Tigason (RO 10-9359).
El-Ramly M; Zachariae H
Acta Derm Venereol; 1983; 63(5):452-6. PubMed ID: 6197852
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatoses.
Viglioglia PA
Br J Dermatol; 1980 Nov; 103(5):483-7. PubMed ID: 7437314
[TBL] [Abstract][Full Text] [Related]
17. [Tolerability of an aromatic retinoid (RO 10 9359, etretinate, Tigason, Roche). Research on its toxicity on hematopoietic, renal and thyroid functions. Interactions with the metabolism of natural retinoids].
Fontan B; Bonafé JL; Moatti JP
Ann Dermatol Venereol; 1983; 110(1):23-31. PubMed ID: 6859752
[TBL] [Abstract][Full Text] [Related]
18. [Bone complications from chronic etretinate intoxication in children].
Cointin M; Sommelet-Olive D; Cuny JF; Bretagne MC
Ann Pediatr (Paris); 1990 Sep; 37(7):458-60. PubMed ID: 2256641
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
Burge SM; Wilkinson JD; Miller AJ; Ryan TJ
Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pityriasis rubra pilaris with an oral aromatic retinoid (RO 10--9359).
Lauharanta J; Lassus A
Acta Derm Venereol; 1980; 60(5):461-2. PubMed ID: 6162329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
